BioNexus Gene Lab
BGLC
$0.42
Share price
-3.48%
Change (1 day)
63.38%
Change (1 year)
Categories
BioNexus Gene Lab (BGLC) - Cash on Hand
Cash on Hand as of March 2024 : $5.83 M
According to BioNexus Gene Lab's latest financial reports the company has $5.83 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
BioNexus Gene Lab - Cash on Hand chart (from 2019 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $2.11 M | -0.24% |
| 2021-12-31 | $2.12 M | -23.81% |
| 2020-12-31 | $2.78 M | 224.5% |
| 2019-12-31 | $0.85 M | -31.83% |
| 2018-12-31 | $1.26 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | 5,331.55% | 🇺🇸 USA |